"Stable" ventricular tachycardia is not a benign rhythm: Insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry

Circulation

Volumn 103, Issue 2, 2001, Pages 244-252

  Raitt, Merritt H ^a,h   Renfroe, Ellen Graham ^b   Epstein, Andrew E ^c   McAnulty, John H ^d   Mounsey, Paul ^e   Steinberg, Jonathan S ^f   Lancaster, Scott E ^b   Jadonath, Ram L ^g   Hallstrom, Alfred P ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

^f ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^g NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^h AVID Clinical Trial Center   (United States)

Author keywords

Cardioversion; Death, sudden; Defibrillation; Tachycardia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0035895331     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.2.244     Document Type: Article

References (10)

1. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
2. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction?
3. Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation
4. Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest
5. Design and results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry
6. Determinants of survival in patients with ventricular tachyarrhythmias
7. Long-term outcome of survivors of cardiac arrest whose therapy is guided by electrophysiologic testing
8. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial
9. Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction
10. Exploration of the precision of classifying sudden cardiac death: Implications for the interpretation of clinical trials